PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia · Delayed Price · Currency is IDR 234.00
-2.00 (-0.85%)
Last updated: Sep 2, 2026, 11:50 AM WIB
IDX:OBAT Revenue
PT Brigit Biofarmaka Technologi Tbk had revenue of 45.18B IDR in the quarter ending June 30, 2026, a decrease of -4.98%. This brings the company's revenue in the last twelve months to 172.56B, up 21.15% year-over-year. In the year 2025, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 160.12B with 32.74% growth.
Revenue (ttm)
172.56B
Revenue Growth
+21.15%
P/S Ratio
0.93
Revenue / Employee
10.15B
Employees
17
Market Cap
160.57B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 160.12B | 39.49B | 32.74% |
| Dec 31, 2024 | 120.63B | 63.70B | 111.89% |
| Dec 31, 2023 | 56.93B | 18.43B | 47.89% |
| Dec 31, 2022 | 38.50B | 642.48M | 1.70% |
| Dec 31, 2021 | 37.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Wahana Pronatural Tbk | 1.67T |
| PT Indo Oil Perkasa Tbk | 1.30T |
| PT Dua Putra Utama Makmur Tbk | 1.09T |
| PT Indo American Seafoods Tbk | 703.93B |
| PT Panca Mitra Multiperdana Tbk | 658.10B |
| PT Morenzo Abadi Perkasa Tbk | 461.45B |
| PT Formosa Ingredient Factory Tbk | 184.74B |
| PT Raja Roti Cemerlang Tbk | 122.23B |